BIOMAT Database Logo BIOMAT Database Logo

[Clinical study of heptaminol acefyllinate]. 1967

P Queneau, and J Le Guyader, and Detry, and M Pont

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009748 Nutrition Disorders Disorders caused by nutritional imbalance, either overnutrition or undernutrition. Nutritional Disorders,Nutrition Disorder,Nutritional Disorder
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000605 Amino Alcohols Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2). Alcohols, Amino

Related Publications

P Queneau, and J Le Guyader, and Detry, and M Pont
[Comparative effects of heptaminol hydrochloride and acefyllinate on curarization].
January 1972, Comptes rendus des seances de la Societe de biologie et de ses filiales,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Clinical trials of heptaminol acefyllinate in the prevention of hypotension following neuroleptic treatment].
April 1969, Annales medico-psychologiques,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Effects of heptaminol acefyllinate on cardiovascular disorders due to neuroleptic treatment].
July 1970, Annales medico-psychologiques,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Verification of the efficacy of heptaminol acefyllinate in asthmatics and chronic respiratory insufficient patients].
March 1971, Bordeaux medical,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Clinical use of heptaminol chlorhydrate].
September 1961, Bruxelles medical,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Clinical use of heptaminol chlorhydrate].
October 1961, Bruxelles medical,
P Queneau, and J Le Guyader, and Detry, and M Pont
Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products.
January 2013, Analytical chemistry insights,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Pharmacodynamic study of theophylline-heptaminol acetate].
January 1965, Therapie,
P Queneau, and J Le Guyader, and Detry, and M Pont
[Clinical trial of heptaminol acephyllinate. Apropos of 40 cases].
January 1967, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
P Queneau, and J Le Guyader, and Detry, and M Pont
[CARDIOVASCULAR EFFECTS OF HEPTAMINOL HYDROCHLORIDE. CLINICAL AND POLYGRAPHIC EVALUATION].
January 1965, Minerva cardioangiologica,
Copied contents to your clipboard!